A Comparative study of Duralabhadileha and Vasavaleha in the management of Tamaka Shwasa (Childhood Asthma) in the age group of 5 to 12 years.
Phase 1
- Conditions
- Health Condition 1: J069- Acute upper respiratory infection,unspecified
- Registration Number
- CTRI/2019/09/021012
- Lead Sponsor
- College of Ayurveda and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Subject having age group 5 to 12 years will be selected irrespective of gender with following criteria.
2. Classical symptoms of TAMAKA Shawasa as per CharakSamita(Chikitsa 17/60)like kasa(cough) ,urahghurghrta(wheezing) , shwaskrichhata(dyspnea) etc of mild to moderate degree.5
3. Patient suffered with at least2 attack of dyspnoea will be selected.
4. Patient already on Inhaled corticosteroid (ICS) for acute attack will be taken after discontinuation of treatment.
Exclusion Criteria
1. Severe case of Asthma like status asthmatics
2. Known case of acute respiratory infection like pneumonia, Bronchitis, whooping cough.
3. Known case of congenital heart disease.
4. Known case of chronic infections like Tuberculosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of Duralabhadileha and Vasavaleha in the management of Tamaka Shwasa Avegavastha.Timepoint: 30 days with follow up on 7th 15th 21st 30th day
- Secondary Outcome Measures
Name Time Method To observe the adverse effect of Duralabhadileha and Vasavaleha in <br/ ><br>the management of TAMAKA Shwasa Avegavastha, if any. <br/ ><br>Timepoint: 30 DAYS